WallStreetZenWallStreetZen

NASDAQ: CLLS
Cellectis Sa Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CLLS past revenue growth

How has CLLS's revenue growth performed historically?
Company
-20.71%
Industry
73.78%
Market
17.41%
CLLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLLS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLLS earnings and revenue history

Current Revenue
$19.6M
Current Earnings
-$80.0M
Current Profit Margin
-407.3%

CLLS Return on Equity

Current Company
-80%
Current Industry
22.8%
Current Market
33.8%
CLLS's Return on Equity (-80%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CLLS announces earnings.

CLLS Return on Assets

Current Company
-24.5%
Current Industry
3.5%
CLLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CLLS Return on Capital Employed

Current Company
-20.1%
Current Industry
21.4%
CLLS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLLS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CLLS$19.64M-$30.80M-$79.97M+11.54%N/A
OMER$0.00-$106.80M-$140.04M-100.00%N/A
NKTR$93.16M-$146.03M-$177.08M-4.80%N/A
CABA$0.00-$84.13M-$89.98MN/AN/A
ACRV$0.00-$67.42M-$69.00MN/AN/A
View Top Biotech Stocks

CLLS earnings dates

Next earnings date
Nov 4, 2024

Cellectis Sa Earnings & Revenue FAQ

What were CLLS's earnings last quarter?

Cellectis Sa (NASDAQ: CLLS) reported Q2 2024 earnings per share (EPS) of -$0.32, up 60% year over year. Total Cellectis Sa earnings for the quarter were -$25.27 million. In the same quarter last year, Cellectis Sa's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Cellectis Sa stock.

What was CLLS's earnings growth in the past year?

As of Q3 2024, Cellectis Sa's earnings has grown year over year. Cellectis Sa's earnings in the past year totalled -$79.97 million.

What is CLLS's earnings date?

Cellectis Sa's earnings date is Invalid Date. Add CLLS to your watchlist to be reminded of CLLS's next earnings announcement.

What was CLLS's revenue last quarter?

Cellectis Sa (NASDAQ: CLLS) reported Q2 2024 revenue of $9.50 million up 374.96% year over year. In the same quarter last year, Cellectis Sa's revenue was $2.00 million.

What was CLLS's revenue growth in the past year?

As of Q3 2024, Cellectis Sa's revenue has grown -20.71% year over year. This is 94.48 percentage points lower than the US Biotechnology industry revenue growth rate of 73.78%. Cellectis Sa's revenue in the past year totalled $19.64 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.